Summit Therapeutics Notes That Data From The Phase III HARMONi-GI1 Trial Will Be Presented At The European Society For Medical Oncology Congress, October 23–27

뉴스 본문을 불러오고 있어요.

Summit Therapeutics Notes That Data From The Phase III HARMONi-GI1 Trial Will Be Presented At The European Society For Medical Oncology Congress, October 23–27 | 웨이프 WAPE

Summit Therapeutics Notes That Data From The Phase III HARMONi-GI1 Trial Will Be Presented At The European Society For Medical Oncology Congress, October 23–27

기사 요약

관련 종목

댓글 —